Ganesh Kaundinya

Ganesh is an entrepreneur and seasoned executive with a track record of creating impact in the biotech and healthcare sector. As the Founder, CSO and COO, of Momenta Pharmaceuticals he built the company from a nascent technology concept to a multi-billion dollar, publicly traded enterprise with 3 FDA-approved commercial products.

Momenta Pharmaceuticals was acquired by Johnson and Johnson for US $6.5 Billion in August 2020. Presently, Ganesh is mentoring, and on the board of multiple early stage companies, working with investors and management teams to translate scientific innovations, develop corporate strategy and raise capital. Previously, Ganesh was a research faculty member at the Harvard-MIT Division of Health Sciences and Technology and later at the MIT Division of Bioengineering. He was the Director of Bioinformatics at MIT for a multi-center project on evaluating roles of complex polysaccharides in biology.